Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Jenburkt Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Jenburkt Pharmaceuticals Ltd (JENBURPH-BY)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 11 $25.00

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review Summary Jenburkt Pharmaceuticals Limited (JPL) is...

19 May 2016 GlobalData 21 $125.00

Wright Investors Service Comprehensive Report for Jenburkt Pharmaceuticals.Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 May 2016 Wright Reports 55 $75.00

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review Summary Jenburkt Pharmaceuticals Limited (JPL) is...

21 Mar 2016 GlobalData 21 $125.00

Is Now the Time to Buy Jenburkt Pharmaceuticals Ltd?

01 Feb 2016 Sadif Analytics Prime 12 $25.00

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review Summary Jenburkt Pharmaceuticals Limited (JPL) is...

18 Dec 2015 GlobalData 21 $125.00

Jenburkt Pharmaceuticals Ltd: Downgraded to Above Average

13 Nov 2015 Sadif Analytics Prime 3 $10.00

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review

Jenburkt Pharmaceuticals Limited (524731) - Financial Analysis Review Summary Jenburkt Pharmaceuticals Limited (JPL) is...

08 Sep 2015 GlobalData 21 $125.00

Jenburkt Pharmaceuticals Ltd: Downgraded to Average

21 Jul 2015 Sadif Analytics Prime 3 $10.00